132185Evaluating the efficacy of H2O2 vapour against biofilms formed by multi-drug resistant organisms (MDROsClosedFeasibility StudiesInnovate UKThe project aims to evaluate the efficacy of Bioquell's 35% hydrogen peroxide vapour (HPV) technology against single and multi-species biofilms, produced by multi-drug resistant organisms (MDROs) associated with hospital acquired infection. Recent evidence shows that biofilms can survive in excess of 12 months on surfaces within hospital rooms, even after terminal cleaning with bleach. It is believed that these biofilms act as reservoirs for infection, with the potential to contaminate patients who come into contact with them. Bioquell is working in conjunction with University of Southampton.